viewZoetic International PLC

Zoetic makes three-pronged change to streamline its cultivation strategy

It is expanding its seed testing programme; it is terminating the lease on its Colorado production facility; and it has struck a European joint-venture to grow high-quality hemp seeds

Zoetic International PLC -

Zoetic International PLC (LON:ZOE) has made a three-pronged change to streamline its cultivation strategy.

The cannabinoid (CBD) specialist is expanding its seed testing programme via a partnership with GVB Biopharma; it is terminating the lease on its Colorado production facility; and it has struck a European joint-venture to grow high-quality hemp seeds.

In working with GVB, it said it wants to avoid the problems faced by certain Kentucky and North Carolina-based competitors that have based their products around what appears to be genetically-deficient hemp seed stocks.

“With the CBD industry becoming increasingly litigious, now is not the time to make uninformed business decisions and we strongly believe that by entering into this partnership, Zoetic will be better positioned to take data-driven action to move the company and its products forward," said joint chief executive, Antonio Russo in a statement.

The maker of the Chill tobacco alternative brand, said the closure of its Colorado leasehold facility would allow the business to scale “in line with both development and demand”, while reducing, in the short-term at least, one of its most significant overheads.

"As our Chill products enjoy sustained growth in their popularity, now is the right time to modernise the company's infrastructure and bring production into line with our vision,” said co-CEO Trevor Taylor.

“Although our facility in Colorado has served us well, we look forward to the new opportunities that other global cultivation sites offer whilst reducing one of the Company's most significant overhead costs."

As a further step into new global markets, Zoetic has struck a JV deal with an unnamed but “trusted” European cultivation partner.

With correct market positioning and appropriate legal protections in place, there is scope for Zoetic to be a leading UK/EU provider of high calibre hemp seed genetics, it added.

“With the movement of seed cultivation operations to Europe, Zoetic is set to scale the growth of its seed offerings as field trials in the US are completed," Taylor explained.

Quick facts: Zoetic International PLC

Price: 58.8 GBX

Market: LSE
Market Cap: £115 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zoetic International PLC named herein, including the promotion by the Company of Zoetic International PLC in any Content on the Site, the...


Zoetic forms second international distribution contract to reach over 15...

Zoetic International PLC (LON:ZOE) Co-CEOs Antonio Russo and Trevor Taylor tell Proactive the London-listed vertically integrated CBD company has signed its second international distribution contract, as well as noting continued progress with its core CBD business. Russo and Taylor say the...

on 09/10/2020

2 min read